Home » Topics » Substance use and poisoning, BioWorld Science

Substance use and poisoning, BioWorld Science
RSS

Novel sigma receptor antagonists combat cocaine-induced behavioral toxicity

Oct. 23, 2006

Desoxypeganine shows good pharmacokinetic profile in healthy volunteers

Oct. 11, 2006

Lofexidine studied for treatment of opiate withdrawal symptoms in phase III trial

Oct. 11, 2006

European approval for Suboxone for treatment of opioid dependence

Oct. 6, 2006

Alkermes developing oral products for treatment of addiction

Oct. 5, 2006

Champix approved in Europe

Oct. 2, 2006

PharmAthene awarded Department of Defense contract for Protexia development

Sep. 27, 2006

ArmaGen receives grant to develop first nerve gas antidote

Sep. 20, 2006

SBIR grant for Cleveland BioLabs' radioprotector research

Sep. 12, 2006

Aktiv-Dry awarded grant to develop inhalable nicotine vaccine

Sep. 4, 2006

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 24, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 21, 2026
A free gene therapy? Regeneron’s Otarmeni approved for hearing loss
BioWorld
Children and adults with a type of congenital hearing loss now have a free treatment option, with the U.S. FDA’s accelerated approval of Regeneron Pharmaceuticals...
Psychedelic space expanding on Trump’s EO
BioWorld
Timothy Leary is dead, but he could be on the outside looking in with a smile on his face as U.S. President Donald Trump’s latest executive order (EO) fuels a...
At AACR: Epigenetic fingerprints in metastases track tumor origin
BioWorld
When a tumor migrates and colonizes another tissue or organ, it can be identified as a metastasis, but its origin is not always clear. Now, a study based on...